Try a single issue or save on a subscription Issues delivered straight to your door or device ...

Obstructive sleep apnea (OSA) is very common with 15% to 30% of men in the United States and 10% to 15% of women having the ...

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

New research provides guidance on the effects of caffeine, diet and naps on sleep. Plus there are expanded treatments for ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

From sleep apnea-fighting mattresses to smart rings that play lullabies, the best sleep tech from Day 1 of CES 2025 ...

The "Sleep Apnea Devices Market Forecast Report by Types, Therapeutic Devices, Diagnostic Devices, End User, Country and ...

You don’t realize that you could be sleeping for eight hours but when you get tested you actually only slept for one or two.” ...